A straight-forward set of methods to isolate and determine the identity of the most abundant proteins expressed in skeletal muscle. About 800 spots are discerned on a two-dimensional gel from 10 mg muscle; this allows for the determination of gender-specific protein expression. These methods will give equivalent results in most tissues.
Gross contraction in skeletal muscle is primarily determined by a relatively small number of contractile proteins, however this tissue is also remarkably adaptable to environmental factors1 such as hypertrophy by resistance exercise and atrophy by disuse. It thereby exhibits remodeling and adaptations to stressors (heat, ischemia, heavy metals, etc.)2,3. Damage can occur to muscle by a muscle exerting force while lengthening, the so-called eccentric contraction4. The contractile proteins can be damaged in such exertions and need to be repaired, degraded and/or resynthesized; these functions are not part of the contractile proteins, but of other much less abundant proteins in the cell. To determine what subset of proteins is involved in the amelioration of this type of damage, a global proteome must be established prior to exercise5 and then followed subsequent to the exercise to determine the differential protein expression and thereby highlight candidate proteins in the adaptations to damage and its repair. Furthermore, most studies of skeletal muscle have been conducted on the male of the species and hence may not be representative of female muscle.
In this article we present a method for extracting proteins reproducibly from male and female muscles, and separating them by two-dimensional gel electrophoresis followed by high resolution digital imaging6. This provides a protocol for spots (and subsequently identified proteins) that show a statistically significant (p < 0.05) two-fold increase or decrease, appear or disappear from the control state. These are then excised, digested with trypsin and separated by high-pressure liquid chromatography coupled to a mass spectrometer (LC/MS) for protein identification (LC/MS/MS)5. This methodology (Figure 1) can be used on many tissues with little to no modification (liver, brain, heart etc.).
1. Sample preparation
2. Protein concentration estimation
Use the Lowry assay7 or the BCA assay8 (Pierce); aim for about 4.5 mg ml-1.
3. Isoelectric focusing
Voltage | Time | Volt-Hrs | Ramp | |
Step 1 | 250 | 20 min | Linear | |
Step 2 | 8,000 | 2.5 hr | Linear | |
Step 3 | 8,000 | 40,000 | Rapid | |
Total | 6.5 hr | 40,000 |
4. SDS polyacrylamide gel electrophoresis
5. Gel imaging and analysis
6. In-gel tryptic digestion
For this step a modified Pierce In-Gel Tryptic Digest Kit (#89871X, Pierce) protocol is used.
7. Microscale desalting of peptide extracts
8. Protein identification by HPLC-coupled mass spectrometry
9. Representative Results:
Male and female unexercised, murine skeletal muscle (biceps brachii) was extracted and separated into a two-dimensional map5, the first level of the muscle comparative proteome (Figure 2). Once visualized using high-resolution digital imaging; about 800 protein spots were detected in each. Using the male proteome map as a baseline, it is clear that there are numerous spots that change in abundance in the female proteome. The spot intensities are measures of the change in the protein amounts (Figure 3). The identities of the protein spots that change more than two-fold (up or down) and are statistically significant (p < 0.05) with an n=5 mice, are determined by amino acid sequence analysis using liquid chromatography-coupled mass spectrometry. These results show that females demonstrate an abundance decrease in sugar energy metabolism enzymes and in creatine kinase enzyme (CK) isoforms, a different energy supply system in muscles. Both humans and animals display higher male serum CK levels at rest and following exercise9,10, but serum CK levels do not necessarily correlate with the amount of myofibrillar disruption11,12. This gender dimorphism in the cellular abundance of CK in murine biceps brachii muscle is a novel finding5 and may answer the physiologically different serum CK levels.
Figures:
Figure 1. An overall schematic of the protocol for comparative proteomics. The protocol is subdivided into three groups: sample preparation; sample analysis; and, protein identification. The ends of each of these three groups of protocols are also reasonable pausing places, although the best results are garnered if the overall protocol is carried out without stopping.
Figure 2. Comparison of female murine biceps brachii protein spots relative to the identical spots in male biceps brachii (green circles o). Spots that increased greater than or equal to two-fold in females are circled red (o) and those that decreased less than or equal to two-fold are circled blue (o).
Figure 3. Gel Spot Intensity Analysis: X-axis, female pre-exercise (control, n=5); Y-axis, female single bout 0 hr time point group (n=5). Regression line: correlation coefficient = 0.919; slope = 0.976; intercept = -0.0293. Spots above the red line and below the blue line change more than +/- two-fold.
The LC/MS proteomics method presented here is a most reliable and reproducible protocol for a rapid analysis of the first level of the skeletal muscle proteome. It allows for a reasonably expedient comparison of gender specificity. Low abundance proteins would require a fractionation of the muscle sample to remove as many of the contractile proteins as possible, thereby increasing the low abundance proteins. Tailoring the proteome profile can be accomplished with differing pH range IPG strips and alternate percentage gradient gels if desired. More sensitive fluorescent stains exist, but we recommend that each laboratory determine the linearity of these stains in your system. For a more rigorous analysis of protein expression the DIGE system (two-Dimensional In-Gel Electrophoresis system, GE Healthcare Life Sciences) can be used, however this does add a level of complexity to the methodology. Further, the protocol herein described can be used with most animal tissues for which a genome has been sequenced, as well as de novo sequencing of a protein from any source, as long as it can be resolved on a two-dimensional gel, since overlapping enzymatic fragments can be generated using high purity enzymes in addition to trypsin. Samples from other tissue sources may require some alterations in the extraction methodology, especially if looking for membrane and hydrophobic proteins, however, we have had good results using this protocol with cardiac, liver, kidney and brain tissues. Other post-translational modifications may be detected by modifying the mass spectrum database search criteria. In sum, we have presented a reasonably detailed initial protocol for proteome profiling analysis.
The authors have nothing to disclose.
We thank Yutian Gan for use of Figure 3. This work was supported by National Science Foundation 0420971; the Smith College Blakeslee, Wilens and Holmes funds; and the Howard Hughes Medical Institute.
Name of the reagent | Typ | Company | Catalogue number | Comments |
---|---|---|---|---|
PepClean C-18 Spin Columns |
Consumable | ThermoFisher Scientific |
PI-89870 | |
Pepswift monolithic column (100um x 5 cm) |
Consumable | Dionex | 162348 | |
Criterion pre-cast 10.5%-14% Tris-HCl SDS polyacrylamide gels |
Consumable | BioRad | 345-0106 | |
Readystrip IPG strips | Consumable | BioRad | Varying pH ranges |
|
Acetic acid | Reagent | Fisher Scientific | A465-1 | |
Acetone | Reagent | Pharmco | 329000 | |
Acetonitrile | Reagent | Fisher Scientific | A955 | |
Agarose | Reagent | BioRad | 163-2111 | Overlay solution |
Ammonium bicarbonate | Reagent | Fluka | 40867 | |
Bromophenol blue | Reagent | Fisher Scientific | BP114 | |
Bio-Lyte Ampholytes | Reagent | BioRad | Varying pH ranges |
|
CHAPS | Reagent | USB | 13361 | |
Commassie blue R-250 | Reagent | ThermoFisher Scientific |
20278 | |
Dithiothreitol (DTT) | Reagent | USB | 15395 | |
Formic acid | Reagent | ThermoFisher Scientific |
28905 | |
Glycerol | Reagent | Sigma-Aldrich | G6279 | |
Glycine | Reagent | USB | 16407 | |
Iodoacetamide | Reagent | Sigma-Aldrich | I6125 | |
Methanol | Reagent | Fisher Scientific | A452 | |
Mineral oil | Reagent | BioRad | 163-2129 | |
Sodium dodecyl sulfate | Reagent | Sigma-Aldrich | L6026 | |
Tris base | Reagent | Sigma-Aldrich | 93349 | |
Tris[2-carboexyethyl] phosphine |
Reagent | ThermoFisher Scientific |
77720 | |
Trypsin Endoproteinase, TPCK treated, MS grade |
Reagent | Pierce | 90055 | modified |
Urea | Reagent | USB | 75826 | |
Water | Reagent | Burdick& Jackson |
365 | |
Centrivap Concentrator | Tool | Labconco | ||
Exquest spot cutter | Tool | BioRad | ||
LCQ Deca XP Max ion trap mass spectrometer |
Tool | ThermoFisher Scientific |
||
Motorized pestle | Tool | Kontes Corp | ||
Polypropylene stirring | Tool | BioSpec Prod | ||
rods | ||||
PROTEAN IEF cell | Tool | BioRad | ||
Sonicator | Tool | Branson | ||
Surveyor Plus HPLC system |
Tool | ThermoFisher Scientific |
||
VersaDoc imaging system |
Tool | BioRad |